Tempus ECG-Low EF vs VX1+
AI Verdict
Choose Tempus ECG-Low EF if…
Choose Tempus ECG-Low EF if your primary objective is to screen and identify patients aged 40 or older at risk of heart failure by detecting signs of low left ventricular ejection fraction from standard 12-lead ECGs. This tool is ideal for general clinical diagnostic settings, emergency medicine, or internal medicine to aid in early risk stratification and guide further diagnostic evaluation for potential heart failure.
View Tempus ECG-Low EF →Choose VX1+ if…
Choose VX1+ if you are an electrophysiologist performing cardiac ablation procedures for atrial fibrillation or atrial tachycardia and require real-time AI-powered assistance to identify abnormal electrograms. This tool is specifically designed to enhance procedural effectiveness by providing immediate insights into spatio-temporal dispersed electrograms, integrating with existing EP recording and 3D mapping systems.
View VX1+ →Reviewed by Pouyan Golshani, MD — Interventional Radiologist
Quick Comparison
| Feature | Tempus ECG-Low EF | VX1+ |
|---|---|---|
| Deployment | Integrates with current ECG platforms and electronic health records (EHRs). | Software, compatible with most multipolar catheters and mapping technologies used in operating rooms or electrophysiology labs. |
| FDA Status | Cleared AI-estimated | Cleared AI-estimated |
Head-to-Head
AI-generated assessment across six dimensions based on each tool's documented features and compliance posture. Grounded in public data — not a substitute for hands-on evaluation.
Usability
Tempus ECG-Low EFTempus ECG-Low EF (Tool A) operates primarily in the background, integrating into existing healthcare facility workflows and electronic health record systems without a dedicated user interface, providing a binary output for interpretation. This seamless, unobtrusive integration minimizes clinician burden. In contrast, VX1+ (Tool B) is an interactive, real-time tool used during complex cardiac ablation procedures, requiring direct engagement with its color-coded interface.
Clinical Value
Tempus ECG-Low EFTempus ECG-Low EF (Tool A) is an FDA-cleared AI software that provides scalable screening for low LVEF, a risk factor for heart failure, in a broad patient population, with validated sensitivity and specificity (85.8% and 83.0% respectively). This offers significant potential for earlier detection and intervention for a prevalent condition. While VX1+ (Tool B) offers real-time assistance during complex ablation procedures with promising outcomes in specialized studies, its clinical significance for guiding ablation outcomes is still being further established through ongoing trials.
Pricing & Value
TieNeither Tempus ECG-Low EF (Tool A) nor VX1+ (Tool B) have publicly available pricing information. Without any details on their cost or pricing models, it is not possible to conduct a meaningful comparison of their value proposition. Therefore, this dimension is a tie.
Enterprise Readiness
Tempus ECG-Low EFTempus ECG-Low EF (Tool A) explicitly states it is HIPAA compliant and offers a Business Associate Agreement (BAA) in the provided facts, and is developed by Tempus AI, a large, established company with a broad AI portfolio and existing EHR integration capabilities. While Volta Medical (Tool B's company) states a commitment to compliance and has safeguards, the explicit BAA and HIPAA compliance are not stated in the initial facts for VX1+, making Tool A appear more explicitly ready for enterprise deployment.
Innovation
VX1+Both tools are innovative, but VX1+ (Tool B) demonstrates a higher degree of innovation by providing real-time, AI-driven guidance during complex, interventional cardiac ablation procedures, a first in interventional cardiac electrophysiology. This involves dynamic analysis and interaction within a critical operating room environment. Tempus ECG-Low EF (Tool A) is innovative in applying AI to standard ECGs for a novel, scalable screening purpose, but VX1+'s application is arguably more technically challenging and directly impacts an invasive procedure.
Support & Docs
TieThe provided structured facts offer no specific information regarding support and documentation for either Tempus ECG-Low EF (Tool A) or VX1+ (Tool B). While general company support channels and some documentation (e.g., user manuals, resource centers) are mentioned in web searches for both Tempus AI and Volta Medical, there is insufficient detail to differentiate between the two products on this dimension. Therefore, this dimension is a tie.
Feature-by-Feature
Detail beyond the Quick Comparison summary. For pricing, deployment, BAA, FDA, and HIPAA see the Overview tab.
| Feature | Tempus ECG-Low EF | VX1+ |
|---|---|---|
| Company | Tempus AI | Volta Medical |
| Primary Purpose | Analyzes 12-lead ECG recordings to detect signs associated with low left ventricular ejection fraction (LVEF u226440%) in patients 40 years or older at risk of heart failure. | Assists electrophysiologists in real-time identification of abnormal electrograms during cardiac ablation procedures for atrial fibrillation and atrial tachycardia. |
| Target Condition/Application | Detection of signs associated with low Left Ventricular Ejection Fraction (LVEF u226440%) in patients 40+ years at risk of heart failure. | Real-time identification of abnormal electrograms during cardiac ablation procedures for atrial fibrillation and atrial tachycardia. |
| Key Output/Function | Provides a binary output (Low LVEF Detected / Not Detected) to aid clinicians in further evaluation. | Real-time manual or automatic annotation of 3D anatomical and electrical maps, identification of spatio-temporal dispersed electrograms (DEs), AI-driven insights. |
| Specialties | Cardiology, Emergency Medicine, Internal Medicine | Cardiology |
Videos
Demos, reviews, and walkthroughs featuring Tempus ECG-Low EF and VX1+.
Frequently Asked Questions
More Comparisons
More matchups featuring Tempus ECG-Low EF or VX1+
Backers
Who funded each tool's parent company.